01-06-2025
MGM successfully treats blood cancer patient with CAR T-Cell therapy
Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so.
Tired of too many ads? go ad free now
"The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy.
Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells.
A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them.
In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said.
Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others.
Tired of too many ads? go ad free now
Indore: MGM Medical College on Saturday announced its successful treatment of a blood cancer patient using CAR T-cell therapy, making it the first govt medical institution in the state to do so.
"The groundbreaking treatment was carried out under the supervision of department of clinical haematology, transfusion medicine, and bone marrow transplant," MGMMC dean Dr Arvind Ghanghoria said. He added that the patient, whose treatment began on Jan 26 this year at the Super Speciality Hospital, was successfully discharged on Saturday, four months after the therapy.
Explained the CAR T-cell therapy process, Dr Ghanghoria said, "The patient undergoes an apheresis procedure to remove white blood cells. A normal patient's blood contains two types of white blood cells, B and T cells. T cells are separated from the white blood cells and then genetically modified using viral vectors. These genetically modified CAR T-cells are then re-infused into the patient. The Chimeric Antigen Receptor identifies specific proteins on the surface of cancer cells and destroys them.
In this way, CAR T-cells eliminate cancer from the patient's body, leading to a cancer-free life," he said.
Head of clinical haematology department Dr Akshay Lahoti highlighted that similar CAR T-cell therapy treatments abroad can cost up to Rs 4 crore. He extended gratitude for the extensive support received from various individuals and organisations, including Dr Rahul Bhargava (head haematologist, Fortis Hospital), Dr Sudhir Kataria, Dr Preeti Malpani, Dr Prachi Chaudhary, Dr Ashok Yadav, Dr Sumit Shukla, and others.
